Your browser is no longer supported. Please, upgrade your browser.
Settings
RLMD [NASD]
Relmada Therapeutics, Inc.
Index- P/E- EPS (ttm)-4.40 Insider Own1.60% Shs Outstand16.57M Perf Week-2.37%
Market Cap534.51M Forward P/E- EPS next Y-5.71 Insider Trans-31.32% Shs Float16.38M Perf Month-16.85%
Income-71.00M PEG- EPS next Q-1.47 Inst Own58.80% Short Float6.30% Perf Quarter-12.94%
Sales- P/S- EPS this Y-392.00% Inst Trans2.20% Short Ratio11.90 Perf Half Y-11.60%
Book/sh5.50 P/B5.63 EPS next Y4.20% ROA-58.90% Target Price- Perf Year-35.20%
Cash/sh5.95 P/C5.20 EPS next 5Y- ROE-62.90% 52W Range28.40 - 54.00 Perf YTD-3.49%
Dividend- P/FCF- EPS past 5Y-30.00% ROI- 52W High-42.69% Beta0.33
Dividend %- Quick Ratio8.20 Sales past 5Y- Gross Margin- 52W Low8.98% ATR1.58
Employees14 Current Ratio8.20 Sales Q/Q- Oper. Margin- RSI (14)38.37 Volatility3.37% 5.40%
OptionableYes Debt/Eq0.00 EPS Q/Q-85.10% Profit Margin- Rel Volume0.75 Prev Close30.90
ShortableYes LT Debt/Eq0.00 EarningsMay 12 AMC Payout- Avg Volume86.68K Price30.95
Recom1.30 SMA20-5.83% SMA50-11.26% SMA200-11.72% Volume64,941 Change0.16%
May-20-21Resumed Goldman Buy $78
Oct-28-20Downgrade Goldman Buy → Neutral $69 → $40
Jul-14-20Initiated Oppenheimer Outperform $75
May-04-20Initiated SunTrust Buy $75
Apr-21-20Initiated Goldman Buy $63
Jan-27-20Initiated Jefferies Buy $75
Jan-10-20Initiated SVB Leerink Outperform $50
Dec-16-19Initiated Guggenheim Buy $64
Jun-15-21 08:00AM  
Jun-07-21 08:30AM  
Jun-01-21 08:30AM  
04:23AM  
May-26-21 08:00AM  
May-24-21 10:19AM  
May-12-21 04:10PM  
02:30PM  
May-06-21 04:30PM  
May-01-21 08:30AM  
Apr-29-21 08:30AM  
Apr-28-21 08:30AM  
Apr-27-21 08:30AM  
Apr-01-21 08:00AM  
Mar-23-21 04:23PM  
02:30PM  
Mar-18-21 05:22PM  
Mar-11-21 08:30AM  
Mar-03-21 02:46AM  
Feb-23-21 08:30AM  
Dec-23-20 08:42AM  
Dec-09-20 03:42PM  
Dec-07-20 08:40AM  
Dec-03-20 02:24AM  
Nov-17-20 08:30AM  
Oct-27-20 08:30AM  
Oct-23-20 06:52AM  
Sep-15-20 01:11PM  
Aug-31-20 10:09AM  
Aug-27-20 02:05PM  
Jul-17-20 09:54AM  
Jul-13-20 08:30AM  
Jul-07-20 07:35AM  
Jun-26-20 07:23AM  
Jun-24-20 04:28PM  
Jun-23-20 08:30AM  
08:30AM  
Jun-09-20 08:34AM  
May-29-20 08:54AM  
May-27-20 08:00AM  
May-26-20 08:00AM  
May-21-20 12:15PM  
May-19-20 07:33AM  
Apr-28-20 08:30AM  
Apr-27-20 09:07AM  
Mar-31-20 08:30AM  
Mar-28-20 10:32AM  
Mar-24-20 08:30AM  
Mar-09-20 08:30AM  
Feb-25-20 09:00AM  
Feb-06-20 10:00AM  
Jan-10-20 08:07AM  
Jan-02-20 07:35AM  
Dec-20-19 08:00AM  
Dec-10-19 08:00AM  
Dec-09-19 04:26PM  
Dec-05-19 07:14AM  
Dec-04-19 07:06AM  
Dec-03-19 11:06PM  
04:10PM  
Nov-19-19 04:58PM  
Nov-13-19 01:46PM  
Oct-17-19 08:30AM  
Oct-15-19 11:26AM  
10:00AM  
08:00AM  
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, an oral agent, which is in Phase II clinical trial for the treatment of depression, neuropathic pain, and other potential CNS pathological conditions. The company is also developing LevoCap ER, an abuse resistant, sustained release dosage form of the opioid analgesic levorphanol; BuTab, an oral dosage form of the opioid analgesic buprenorphine; and MepiGel, an orphan drug designated topical formulation of the local anesthetic mepivacaine. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASAMENTO CHARLES JDirectorJun 01Sale33.343,000100,0206,950Jun 02 05:00 PM
CASAMENTO CHARLES JDirectorMay 03Sale38.223,000114,6479,950May 05 05:00 PM
CASAMENTO CHARLES JDirectorApr 01Sale35.433,000106,28112,950Apr 05 04:08 PM
TRAVERSA SERGIOCEOMar 10Sale35.092,983104,67688,774Mar 11 05:51 PM
Shenouda MagedCFOMar 10Sale35.112,37383,3132,228Mar 10 06:18 PM
Kelly Paul EdwardDirectorMar 09Option Exercise3.245,00016,200172,295Mar 11 05:50 PM
TRAVERSA SERGIOCEOMar 09Option Exercise3.2410,00032,40098,774Mar 11 05:51 PM
Kelly Paul EdwardDirectorMar 09Sale35.715,000178,551167,295Mar 11 05:50 PM
TRAVERSA SERGIOCEOMar 09Sale35.657,017250,16991,757Mar 11 05:51 PM
Shenouda MagedCFOMar 09Sale35.567,527267,6934,601Mar 10 06:18 PM
Shenouda MagedCFOMar 08Option Exercise3.2410,00032,40012,228Mar 10 06:18 PM
Shenouda MagedCFOMar 08Sale35.001003,50012,128Mar 10 06:18 PM
CASAMENTO CHARLES JDirectorMar 01Sale33.873,000101,61815,950Mar 02 04:08 PM
Kelly Paul EdwardDirectorFeb 24Option Exercise3.245,00016,200172,295Feb 26 04:49 PM
TRAVERSA SERGIOCEOFeb 24Option Exercise3.2410,00032,40098,774Feb 26 04:50 PM
TRAVERSA SERGIOCEOFeb 24Sale34.2410,000342,39288,774Feb 26 04:50 PM
Kelly Paul EdwardDirectorFeb 24Sale34.195,000170,933167,295Feb 26 04:49 PM
Kelly Paul EdwardDirectorFeb 16Option Exercise6.005,00030,000167,295Feb 17 06:37 PM
TRAVERSA SERGIOCEOFeb 11Option Exercise3.241,4464,68590,220Feb 16 05:10 PM
Shenouda MagedCFOFeb 11Option Exercise3.241,4284,6273,656Feb 16 05:08 PM
Shenouda MagedCFOFeb 11Sale35.391,42850,5422,228Feb 16 05:08 PM
TRAVERSA SERGIOCEOFeb 11Sale35.431,44651,23888,774Feb 16 05:10 PM
TRAVERSA SERGIOCEOFeb 10Sale35.281,93068,09788,774Feb 10 07:25 PM
Shenouda MagedCFOFeb 10Sale35.202,41084,8252,228Feb 10 07:25 PM
TRAVERSA SERGIOCEOFeb 09Sale35.215,963209,93990,704Feb 10 07:25 PM
Shenouda MagedCFOFeb 09Sale35.245,359188,8434,638Feb 10 07:25 PM
Kelly Paul EdwardDirectorFeb 09Sale35.282,06973,005162,295Feb 10 07:25 PM
Kelly Paul EdwardDirectorFeb 08Option Exercise3.243,56911,564165,864Feb 10 07:25 PM
Shenouda MagedCFOFeb 08Option Exercise3.2411,37236,84513,600Feb 10 07:25 PM
TRAVERSA SERGIOCEOFeb 08Option Exercise3.2411,20636,30799,980Feb 10 07:25 PM
Shenouda MagedCFOFeb 08Sale35.043,603126,2429,997Feb 10 07:25 PM
TRAVERSA SERGIOCEOFeb 08Sale35.033,313116,04996,667Feb 10 07:25 PM
Kelly Paul EdwardDirectorFeb 08Sale35.041,50052,560164,364Feb 10 07:25 PM
TRAVERSA SERGIOCEOFeb 03Sale35.001003,50088,874Feb 04 05:40 PM
Shenouda MagedCFOFeb 03Sale35.001003,5002,228Feb 04 05:38 PM
Shenouda MagedCFOFeb 02Option Exercise3.243,20010,3685,428Feb 04 05:38 PM
TRAVERSA SERGIOCEOFeb 02Option Exercise3.2413,28143,03088,774Feb 04 05:42 PM
TRAVERSA SERGIOCEOFeb 02Option Exercise3.243,27810,62192,052Feb 04 05:40 PM
Shenouda MagedCFOFeb 02Sale35.043,100108,6342,328Feb 04 05:38 PM
TRAVERSA SERGIOCEOFeb 02Sale35.083,178111,47088,874Feb 04 05:40 PM
Kelly Paul EdwardDirectorFeb 02Sale35.042,31581,118162,295Feb 03 06:34 PM
Kelly Paul EdwardDirectorFeb 01Option Exercise3.2417,34656,201164,641Feb 03 06:34 PM
CASAMENTO CHARLES JDirectorFeb 01Sale33.633,000100,89818,950Feb 02 05:05 PM
Kelly Paul EdwardDirectorFeb 01Sale35.00311,085164,610Feb 03 06:34 PM
Kelly Paul EdwardDirectorJan 27Option Exercise3.245,00016,200152,295Jan 29 05:20 PM
TRAVERSA SERGIOCEOJan 27Option Exercise3.2410,00032,40085,493Jan 29 05:22 PM
Shenouda MagedCFOJan 27Option Exercise3.243,0009,7205,228Jan 29 05:24 PM
Shenouda MagedCFOJan 27Sale31.933,00095,7782,228Jan 29 05:24 PM
TRAVERSA SERGIOCEOJan 27Sale32.3910,000323,91475,493Jan 29 05:22 PM
Kelly Paul EdwardDirectorJan 27Sale32.465,000162,323147,295Jan 29 05:20 PM
TRAVERSA SERGIOCEOJan 26Sale35.1560021,09075,493Jan 26 07:29 PM
Kelly Paul EdwardDirectorJan 26Sale35.1668524,085147,295Jan 26 07:30 PM
Shenouda MagedCFOJan 26Sale35.1660721,3422,228Jan 26 07:28 PM
TRAVERSA SERGIOCEOJan 25Sale35.291,30045,87776,093Jan 26 07:29 PM
Kelly Paul EdwardDirectorJan 25Sale35.271,30045,851147,980Jan 26 07:30 PM
Shenouda MagedCFOJan 25Sale35.271,28045,1462,835Jan 26 07:28 PM
Shenouda MagedCFOJan 22Option Exercise324.004,0001,296,0006,228Jan 26 07:28 PM
Kelly Paul EdwardDirectorJan 22Option Exercise3.244,08513,235151,380Jan 26 07:30 PM
TRAVERSA SERGIOCEOJan 22Option Exercise3.244,07013,18779,563Jan 26 07:29 PM
Kelly Paul EdwardDirectorJan 22Sale3042.032,1006,388,254149,280Jan 26 07:30 PM
Shenouda MagedCFOJan 22Sale35.552,11375,1244,115Jan 26 07:28 PM
TRAVERSA SERGIOCEOJan 22Sale35.582,17077,21377,393Jan 26 07:29 PM
CASAMENTO CHARLES JDirectorJan 04Sale32.113,00096,34221,950Jan 05 04:00 PM
CASAMENTO CHARLES JDirectorDec 01Sale35.743,000107,21924,950Dec 02 04:01 PM
CASAMENTO CHARLES JDirectorNov 02Sale30.293,00090,86449,173Nov 03 04:03 PM
CASAMENTO CHARLES JDirectorOct 01Sale37.993,000113,95652,173Oct 02 04:02 PM
CASAMENTO CHARLES JDirectorSep 01Sale34.743,000104,20755,173Sep 02 04:36 PM
Kelly Paul EdwardDirectorAug 18Option Exercise3.2422,00071,280149,121Aug 19 04:16 PM
TRAVERSA SERGIOCEOAug 18Option Exercise3.2450,008162,02679,644Aug 19 04:15 PM
CASAMENTO CHARLES JDirectorAug 18Option Exercise3.2426,36285,41360,362Aug 19 04:13 PM
CASAMENTO CHARLES JDirectorAug 03Sale35.743,000107,21334,000Aug 04 03:30 PM
CASAMENTO CHARLES JDirectorJul 01Sale43.893,000131,67737,000Jul 02 01:26 PM